FCCC LOGO Faculty Publications
Sahai E , Astsaturov I , Cukierman E , DeNardo DG , Egeblad M , Evans RM , Fearon D , Greten FR , Hingorani SR , Hunter T , Hynes RO , Jain RK , Janowitz T , Jorgensen C , Kimmelman AC , Kolonin MG , Maki RG , Powers RS , Puré E , Ramirez DC , Scherz-Shouval R , Sherman MH , Stewart S , Tlsty TD , Tuveson DA , Watt FM , Weaver V , Weeraratna AT , Werb Z
A framework for advancing our understanding of cancer-associated fibroblasts
Nat Rev Cancer. 2020 Mar;20(3) :174-186
PMID: 31980749    PMCID: PMC7046529    URL: https://www.ncbi.nlm.nih.gov/pubmed/31980749
Back to previous list
Abstract
Cancer-associated fibroblasts (CAFs) are a key component of the tumour microenvironment with diverse functions, including matrix deposition and remodelling, extensive reciprocal signalling interactions with cancer cells and crosstalk with infiltrating leukocytes. As such, they are a potential target for optimizing therapeutic strategies against cancer. However, many challenges are present in ongoing attempts to modulate CAFs for therapeutic benefit. These include limitations in our understanding of the origin of CAFs and heterogeneity in CAF function, with it being desirable to retain some antitumorigenic functions. On the basis of a meeting of experts in the field of CAF biology, we summarize in this Consensus Statement our current knowledge and present a framework for advancing our understanding of this critical cell type within the tumour microenvironment.
Notes
Export Date: 2 March 2020